Back to Authors

Hozak, Rebecca R.

A5038009127 | I168537998

Mayo Clinic

Eli Lilly (United States)

Citations 2

Mirikizumab Demonstrates Long-Term Efficacy on Histological Resolution in the Phase 3, Multicenter, Open-Label VIVID-2 Extension Study

Zeitschrift für Gastroenterologie | June 8, 2026 | Volume: 64 | Issue: 05 | Pages: e139-e140

10.1055/s-0046-1823082

S982 Association of Histologic-Endoscopic Response and Long-Term Clinical Outcomes: Results From Phase 2 Mirikizumab Trial in Patients With Moderately-to-Severely Active Crohn’s Disease

American Journal of Gastroenterology | October 18, 2023 | Volume: 118 | Issue: 10S | Pages: S740-S741

10.14309/01.ajg.0000953568.00881.40